First Authors : Muserref Kasap Cuceoglu and Dr Tanja Hinze Journal : VRheumatology, Volume 65, Issue 5 Date : May 2026 Article link : https://doi.org/10.1093/rheumatology/keag230 Cross-national access to IL-1 inhibitors in FMF Can patients with colchicine-resistant FMF access IL-1 inhibitors equally, regardless of where they live? A new study from the JIR-CliPS project compared national guidelines, availability and reimbursement policies for IL-1 inhibitors in FMF across 39 countries. The...